Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
T I M E LI NE 2020 | March 24 Workshop: The Role of Digital Health Workshop 3: Application | July 18 Forum Meeting #40 | Technologies in Drug Development (in collaboration with the October 3â4 Forum Meeting #41 | November 28â29 Workshop: Roundtable on Genomics and Precision Health) | March 25 Virtual Clinical Trials: Challenges and Opportunities Forum Meeting #45 | July 8â9 Forum Meeting #46 | August 5â6 Drug R&D for Adults Across the Older Age Span (in collaboration 2017 | March 8 Workshop: Enabling Precision Medicine: The with the Forum on Aging, Disability, and Independence and the Role of Genetics in Clinical Drug Development (in collaboration National Cancer Policy Forum) | October 29 Forum Meeting #47 with the Roundtable on Genomics and Precision Health) | March 9 Forum Meeting #36 | July 10â11 Forum Meeting #37 2019 | March 6â7 Forum Meeting #42 | March 26 Meeting: | September 19â20 Workshop Series: Examining the Impact Updating Labels for Generic Oncology Drugs (in collaboration of Real-World Evidence on Medical Product Developmentâ with the National Cancer Policy Forum) | July 30â31 Forum Workshop 1: Incentives | October 24â25 Forum Meeting #38 Meeting #43 | September 25â26 Workshop: Enhancing Scientific Reproducibility Through Transparent Reporting (in collaboration 2016 | March 12 Workshop: Deriving Drug Discovery Value with the Forum on Neuroscience and Nervous System Disorders, from Large-Scale Genetic Bioresources (in collaboration with the National Cancer Policy Forum, and the Roundtable on the Roundtable on Genomics and Precision Health) | March 23 Genomics and Precision Health) | October 23â24 Forum Meeting Forum Meeting #33 | July 19â20 Forum Meeting #34 | October #44 | November 18â19 Workshop: Sharing Clinical Trial Data: 18 Forum Meeting #35 | October 19 Workshop: Real-World Challenges and a Way Forward (in collaboration with the Forum Evidence Generation and Evaluation of Therapeutics | December on Neuroscience and Nervous System Disorders, the National 12â13 Workshop: The Drug Development Paradigm in Oncology Cancer Policy Forum, and the Roundtable on Genomics and (in collaboration with the National Cancer Policy Forum) Precision Health) 2015 | January 20â21 Workshop: Financial Incentives to 2018 | March 6â7 Workshop Series: Examining the Impact Support Unmet Medical Needs for Nervous System Disorders of Real-World Evidence on Medical Product Developmentâ (in collaboration with the Forum on Neuroscience and Nervous Workshop 2: Practical Approaches | March 19â20 Forum System Disorders) | March 17â18 Forum Meeting #30 | March Meeting #39 | May 9 Workshop: Advancing the Science of Patient 26â27 Workshop: Rapid Medical Countermeasure Response to Input in Medical Product R&D: Towards a Research Agenda | Infectious Diseases: Enabling Sustainable Capabilities Through July 17â18 Workshop Series: Examining the Impact of Real- Ongoing Public- and Private-Sector Partnerships (in collaboration World Evidence on Medical Product Developmentâ with the Forum on Medical and Public Health Preparedness for 36
Disasters and Emergencies) | June 23â24 Forum Meeting #31 | Second-Line Drugs for Multidrug-Resistant Tuberculosis | October 20 Workshop: Advancing the Discipline of Regulatory October 4â5 Workshop: Sharing Clinical Research Data (in Science for Medical Product Development: An Update on collaboration with the Forum on Neuroscience and Nervous Progress and a Forward-Looking Agenda | October 21 Forum System Disorders, the National Cancer Policy Forum, and the Meeting #32 Roundtable on Genomics and Precision Health) | October 23â24 Forum Meeting #23 | November 26â27 Workshop: Large Simple 2014 | February 12 Workshop: Characterizing and Trials and Knowledge Generation in a Learning Health System Communicating Uncertainty in the Assessment of Benefits (in collaboration with the Leadership Consortium for a Value & and Risks of Pharmaceutical Products (Day 1) | March 3â4 Science-Driven Health System) Forum Meeting #27 | May 12 Workshop: Characterizing and Communicating Uncertainty in the Assessment of Benefits and 2011 | March 28 Forum Meeting #18 | March 29â30 Workshop: Risks of Pharmaceutical Products (Day 2) | June 10â11 Forum Advancing Regulatory Science for Medical Countermeasure Meeting #28 | October 7â8 Forum Meeting #29 Development (in collaboration with the Forum on Medical and Public Health Preparedness for Disasters and Emergencies) | 2013 | January 15 Workshop Summary Release: Developing April 18â19 and 21 Workshop: Facing the Reality of Multidrug- and Strengthening the Global Supply Chain for Second-Line Resistant Tuberculosis: Challenges and Potential Solutions Drugs for Multidrug-Resistant Tuberculosis | January 16â18 (New Delhi, India) | June 27â28 Workshop: Public Engagement Workshop: The Global Crisis of Drug-Resistant Tuberculosis and and Clinical Trials: New Models and Disruptive Technologies Leadership of the BRICS Countries (Beijing, China) | February 12 (in collaboration with the Mount Sinai School of Medicine) | Forum Meeting #24 | February 13â14 Workshop: International June 28â29 Forum Meeting #19 | July 12 Workshop Summary Regulatory Harmonization Amid Globalization of Biomedical Release: The Emerging Threat of Multidrug-Resistant Research and Medical Product Development | June 3 Forum Tuberculosis: Global and Local Challenges and Solutions Meeting #25 | October 28â29 Forum Meeting #26 (Durban, South Africa) | September 20â21 Workshop: Strengthening a Workforce for Innovative Regulatory Science in 2012 | March 13â14 Forum Meeting #21 | June 4â5 Workshop: Therapeutics Development | October 4â5 Forum Meeting #20 | Maximizing the Goals of the Cures Acceleration Network to November 7â8 Workshop: Envisioning a Transformed Clinical Accelerate the Development of New Drugs and Diagnostics Trials Enterprise in the United States: Establishing an Agenda | June 5 Forum Meeting #22 | July 31âAugust 1 Workshop: for 2020 | November 15 Workshop Summary Release: The Developing and Strengthening the Global Supply Chain for New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective (Moscow, Russia) 37
T I M E LI NE 2010 | February 23 Workshop: The Public Health Emergency Models: Drug Development for Rare and Neglected Diseases Medical Countermeasures Enterprise (in collaboration with the and Individualized Therapies | June 24 Forum Meeting Forum on Medical and Public Health Preparedness for Disasters #10 | October 24 Workshop: Assessing and Accelerating and Emergencies) | February 26 Workshop: Building a National Development of Biomarkers for Drug Safety | November 2â3 Framework for the Establishment of Regulatory Science for Drug Forum Meeting #11 | November 5 Workshop: Addressing the Development | March 3â4 Workshop: The Emerging Threat of Threat of Drug-Resistant Tuberculosis: A Realistic Assessment Multidrug-Resistant Tuberculosis (Pretoria, South Africa) | of the Challenge April 29â30 Forum Meeting #15 | May 26â27 Workshop: The New Profile of Drug-Resistant Tuberculosis (Moscow, Russia) | 2007 | March 12 Symposium: The Future of Drug Safety: August 5 Forum Meeting #16: Conflict of Interest | October 29 Challenges for FDA | April 23â24 Workshop: Emerging Safety Forum Meeting #17: Administrative and Regulatory Inefficiencies Science | April 24 Forum Meeting #7 | September 14 Discussion in Clinical Trials Series: From Patient Needs to New Drug Therapies: Can We Improve the Pathway? | October 15â16 Forum Meeting #8 | 2009 | February 23 Capitol Hill Briefing: Growing Threat of November 30 Discussion Series: A Conversation with Tony Fauci Drug-Resistant Tuberculosis | March 13 Discussion Series: FDA Community Update on Personalized Medicine and the Genetic 2006 | March 28â29 Forum Meeting #4 | May 30â31 Workshop: Basis of Adverse Events | April 27 Workshop: Streamlining Understanding the Benefits and Risks of Pharmaceuticals | Clinical Trial and Material Transfer Negotiations | April 27â28 June 13 Workshop: Addressing the Barriers to Pediatric Drug Forum Meeting #12 | July 10 Symposium: Drug Regulation with Development | June 27â28 Forum Meeting #5 | October 24â25 FDA Commissioner Peggy Hamburg and Forum Meeting #13 Forum Meeting #6 | September 2 Discussion Series: FDA Community Update: Improving the Science of Drug Safety | October 7â8 Workshop: 2005 | March 23â24 Forum Meeting #1 | June 29â30 Forum Transforming Clinical Research in the United States | October Meeting #2 | September 8â9 Forum Meeting #3 | November 15â16 Forum Meeting #14 3â4 Workshop: Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals 2008 | February 20 Discussion Series: Comparative Effectiveness | February 20â21 Forum Meeting #9 | April 21 2002â2004 | Clinical Research Roundtable, predecessor to Discussion Series: Science at FDA: Challenges and the forum Opportunities | June 23 Workshop: Breakthrough Business 38